GOEL DAVID E. - Insider Non-Derivative Transactions at Zentalis Pharmaceuticals, Inc. (ZNTL) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 20, 2023, GOEL DAVID E.'s relationship to Zentalis Pharmaceuticals, Inc. (ZNTL) is TenPercentOwner, and currently has 13,959,973 shares of Common Stock, par value $0.001 per share.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ZNTL insiders.
Data Source: SEC.
GOEL DAVID E. - Insider Non-Derivative Transactions at ZNTL
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 21, 2023 | P -- (Common Stock, par value $0.001 per share) | 4760000 | 22.66 | 13959973 |